Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Efficacy and safety results show that DD-cxdl would potentially fulfill a serious, unmet medical need for patients with R/R CTCL.
Authors
- Larisa J. Geskin (ORCID: https://orcid.org/0000-0002-0981-3513)
- Nicholas Sauter
- Timothy M. Kuzel (ORCID: https://orcid.org/0000-0002-7523-2397)
- Tatyana A. Feldman (ORCID: https://orcid.org/0000-0002-4458-2896)
- Chean Eng Ooi
- Pamela B. Allen (ORCID: https://orcid.org/0000-0002-3959-3662)
- Christiane Querfeld (ORCID: https://orcid.org/0000-0001-9698-5809)
- Madeleine Duvic (ORCID: https://orcid.org/0000-0002-8971-4565)
- H. Miles Prince (ORCID: https://orcid.org/0000-0002-0058-2448)
- Henry K. Wong (ORCID: https://orcid.org/0000-0001-9181-7195)
- Fernando Cabanillas (ORCID: https://orcid.org/0000-0001-9234-7893)
- Lubomir Sokol
- Costas K. Yannakou (ORCID: https://orcid.org/0000-0001-6657-2034)
- Oleg E. Akilov (ORCID: https://orcid.org/0000-0003-1339-5710)
- Francine M. Foss (ORCID: https://orcid.org/0000-0001-7843-3162)
- Lucia Seminario‐Vidal (ORCID: https://orcid.org/0000-0002-6004-2451)
- David Christopher Fisher (ORCID: https://orcid.org/0000-0001-6915-8584)
- Youn H. Kim (ORCID: https://orcid.org/0000-0003-2686-5873)
- Nam H. Dang
- Myron S. Czuczman
- Dongyuan Xing (ORCID: https://orcid.org/0000-0002-2754-1638)
- Preeti Singh (ORCID: https://orcid.org/0009-0001-5871-4992)
Institutions
- Northwestern University (US)
- Rush University Medical Center (US)
- City Of Hope National Medical Center (US)
- UF Health Shands Hospital (US)
- The University of Texas MD Anderson Cancer Center (US)
- Emory University (US)
- The University of Melbourne (AU)
- Eli Lilly (United States) (US)
- University of South Florida (US)
- Columbia University Irving Medical Center (US)
- Epworth Hospital (AU)
- Peter MacCallum Cancer Centre (AU)
- University of Florida Health (US)
- Moffitt Cancer Center (US)
- Yale University (US)
- UPMC Presbyterian (US)
- Dana-Farber Cancer Institute (US)
- Auxilio Mutuo Hospital (PR)
- University of Pittsburgh Medical Center (US)
- Hackensack Meridian Health (US)
- Eisai (United States) (US)
- University of Florida Health Science Center (US)
- University of Arkansas for Medical Sciences (US)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1200/jco-24-01549
- Citations
- 14
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 7.49